Pricey Pfizer Drug Spurs Call For NIH Collaboration Probe
Sen. Ron Wyden, D-Ore., on Tuesday urged the National Institutes of Health to study whether drugmakers are benefiting excessively from public-private partnerships aimed at developing new medicines, prompting a furious pushback...To view the full article, register now.
Already a subscriber? Click here to view full article